Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients.
Ontology highlight
ABSTRACT: Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.
SUBMITTER: Kim MK
PROVIDER: S-EPMC8169368 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA